Free Trial

Best Biotechnology Stocks

Compare the best biotech stocks to buy today. 

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PricePE RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$167.74
+0.7%
58.24$296.42 billion7.13 million5.49 millionAnalyst Forecast
Positive News
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$512.86
+0.7%
32.15$194.74 billion1.53 million1.49 millionBuyback Announcement
Positive News
Danaher Co. stock logo
DHR
Danaher
$233.10
+1.0%
44.48$168.36 billion2.64 million2.76 millionAnalyst Downgrade
Positive News
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$451.23
+0.7%
N/A$116.21 billion1.64 million1.19 millionNews Coverage
Positive News
GSK plc stock logo
GSK
GSK
$33.36
-0.3%
21.66$69.14 billion7.52 million4.15 millionOptions Volume
Cencora, Inc. stock logo
COR
Cencora
$243.20
+0.9%
32.38$47.92 billion753,9121.40 millionPositive News
Takeda Pharmaceutical Company Limited stock logo
TAK
Takeda Pharmaceutical
$13.29
-2.4%
22.91$42.27 billion3.78 million1.84 millionHigh Trading Volume
Cognizant Technology Solutions Co. stock logo
CTSH
Cognizant Technology Solutions
$77.57
+1.6%
17.16$38.46 billion4.88 million3.84 millionPositive News
argenx SE stock logo
ARGX
argenx
$591.82
+3.0%
N/A$35.39 billion374,800309,599Analyst Forecast
Gap Up
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$194.38
+1.6%
25.51$35.28 billion2.60 million1.17 millionAnalyst Forecast
Analyst Revision
High Trading Volume
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$210.63
+0.4%
56.17$34.11 billion1.17 million953,149Analyst Forecast
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$248.79
+6.2%
N/A$32.09 billion1.06 million879,086Analyst Forecast
BioNTech SE stock logo
BNTX
BioNTech
$102.14
-4.0%
N/A$24.49 billion1.13 million810,578Analyst Forecast
Analyst Revision
News Coverage
Illumina, Inc. stock logo
ILMN
Illumina
$131.68
-2.5%
N/A$20.88 billion3.07 million2.03 millionPositive News
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$237.85
+0.7%
46.01$19.89 billion476,603672,900Positive News
ICON Public Limited stock logo
ICLR
ICON Public
$203.67
+4.1%
22.71$16.80 billion1.84 million719,180Analyst Forecast
Analyst Revision
High Trading Volume
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$364.33
+1.0%
16.00$16.27 billion199,252461,020Positive News
Royalty Pharma plc stock logo
RPRX
Royalty Pharma
$26.22
+0.8%
13.59$15.45 billion2.00 million2.63 million
Moderna, Inc. stock logo
MRNA
Moderna
$36.94
-0.9%
N/A$14.22 billion7.30 million4.78 millionAnalyst Upgrade
Analyst Revision
Suzano S.A. stock logo
SUZ
Suzano
$10.57
+0.7%
16.77$13.99 billion563,5141.79 million
Revvity, Inc. stock logo
RVTY
Revvity
$111.34
+1.3%
53.79$13.55 billion951,508837,289Positive News
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$85.96
-1.3%
N/A$10.71 billion1.72 million895,842
Catalent, Inc. stock logo
CTLT
Catalent
$59.00
+0.2%
N/A$10.71 billion1.41 million2.03 million
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$326.09
+3.5%
28.55$10.13 billion375,972284,342
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$187.90
+1.0%
23.52$9.61 billion632,084625,771Analyst Downgrade
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$334.85
N/A$9.38 billion627
Fabrinet stock logo
FN
Fabrinet
$226.24
-9.0%
26.77$9.02 billion1.17 million493,706Analyst Downgrade
Gap Down
High Trading Volume
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$40.14
+4.5%
N/A$7.32 billion2.24 million1.11 millionAnalyst Revision
High Trading Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$134.84
+1.1%
N/A$6.81 billion1.26 million1.45 millionOptions Volume
News Coverage
Bloom Energy Co. stock logo
BE
Bloom Energy
$24.79
+4.4%
N/A$5.67 billion14.33 million6.47 millionAnalyst Forecast
Gap Down
High Trading Volume
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$82.47
0.0%
N/A$5.67 billion1.58 million1.47 millionInsider Trade
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$178.10
+0.1%
100.62$5.12 billion180,349327,639Positive News
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$31.15
+2.7%
N/A$4.85 billion2.23 million3.70 millionPositive News
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$24.42
+0.3%
N/A$3.51 billion767,9701.07 million
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$4.88
-8.8%
N/A$3.40 billion5.04 million4.98 millionPositive News
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$18.81
-1.4%
9.31$3.05 billion1.70 million945,920Positive News
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$29.99
+1.0%
N/A$3.05 billion1.09 million1.49 millionInsider Trade
Short Interest ↑
Analyst Revision
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$45.75
-0.3%
N/A$2.90 billion401,240907,190
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$9.59
+0.7%
N/A$2.87 billion1.96 million2.72 millionShort Interest ↓
SpringWorks Therapeutics, Inc. stock logo
SWTX
SpringWorks Therapeutics
$37.44
-1.3%
N/A$2.79 billion1.18 million998,408Analyst Forecast
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$8.14
-0.6%
N/A$2.48 billion6.00 million7.33 millionOptions Volume
Twist Bioscience Co. stock logo
TWST
Twist Bioscience
$41.11
-0.5%
N/A$2.41 billion759,188952,883Analyst Forecast
Analyst Revision
News Coverage
Standex International Co. stock logo
SXI
Standex International
$199.28
-2.2%
32.67$2.41 billion37,90755,986
Oddity Tech Ltd. stock logo
ODD
Oddity Tech
$40.31
-0.5%
24.58$2.29 billion197,164663,133
Azenta, Inc. stock logo
AZTA
Azenta
$44.65
+9.1%
N/A$2.18 billion1.94 million510,152Insider Trade
Short Interest ↓
Gap Up
High Trading Volume
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$14.26
+0.4%
N/A$2.17 billion679,4331.12 millionAnalyst Revision
Apogee Therapeutics, Inc. stock logo
APGE
Apogee Therapeutics
$45.04
-3.2%
N/A$2.03 billion347,611493,650
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.49
-3.2%
N/A$2.03 billion912,8271.24 million
Evotec SE stock logo
EVO
Evotec
$5.30
+2.9%
N/A$1.88 billion98,859131,337Short Interest ↓
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$6.04
-3.7%
N/A$1.73 billion16.99 million5.84 millionAnalyst Forecast
Options Volume
High Trading Volume
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$19.15
+2.5%
N/A$1.72 billion1.22 million1.29 million
Galapagos NV stock logo
GLPG
Galapagos
$25.64
-3.9%
N/A$1.69 billion516,276148,647Analyst Downgrade
Short Interest ↓
Gap Down
High Trading Volume
Immunocore Holdings plc stock logo
IMCR
Immunocore
$32.42
-0.4%
N/A$1.62 billion128,283516,049Positive News
10x Genomics, Inc. stock logo
TXG
10x Genomics
$13.32
-1.8%
N/A$1.61 billion1.41 million1.73 million
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$19.79
-2.2%
N/A$1.57 billion1.03 million1.12 millionAnalyst Revision
Arvinas, Inc. stock logo
ARVN
Arvinas
$22.69
+4.9%
N/A$1.56 billion744,090718,161Analyst Forecast
Short Interest ↓
News Coverage
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$7.30
+1.2%
N/A$1.51 billion1.64 million2.93 millionShort Interest ↓
Tutor Perini Co. stock logo
TPC
Tutor Perini
$28.82
-1.8%
N/A$1.51 billion507,081451,849
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$27.50
+2.2%
N/A$1.41 billion1.24 million525,140News Coverage
High Trading Volume
Oaktree Specialty Lending Co. stock logo
OCSL
Oaktree Specialty Lending
$15.68
+0.4%
18.02$1.29 billion996,095662,219Dividend Announcement
Analyst Downgrade
News Coverage
Novavax, Inc. stock logo
NVAX
Novavax
$8.06
+0.8%
N/A$1.28 billion3.47 million9.73 millionAnalyst Revision
Cassava Sciences, Inc. stock logo
SAVA
Cassava Sciences
$26.05
-7.0%
N/A$1.25 billion1.83 million1.70 million
UPB
Upstream Bio
$18.01
-20.8%
N/A$1.22 billion455,696307,711Quiet Period Expiration
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$13.04
-0.9%
N/A$1.19 billion1.28 million792,520Analyst Forecast
News Coverage
Phreesia, Inc. stock logo
PHR
Phreesia
$18.53
-0.1%
N/A$1.07 billion650,881450,777Positive News
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$30.84
+0.2%
24.09$1.04 billion288,930194,694
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$9.08
+0.2%
N/A$1.00 billion1.93 million1.43 millionAnalyst Revision
Zymeworks Inc. stock logo
ZYME
Zymeworks
$14.55
-1.5%
N/A$1.00 billion374,287622,283
Transcat, Inc. stock logo
TRNS
Transcat
$102.83
-1.4%
51.93$946.04 million52,31855,145Positive News
SEPN
Septerna
$22.50
-7.0%
N/A$945.07 million230,571201,544Analyst Forecast
News Coverage
Gap Up
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$6.74
-2.7%
N/A$928.23 million1.47 million1.04 millionAnalyst Forecast
News Coverage
Abrdn Healthcare Investors stock logo
HQH
Abrdn Healthcare Investors
$17.72
+0.5%
N/A$896.99 million176,970158,483Positive News
SLR Investment Corp. stock logo
SLRC
SLR Investment
$16.43
+0.2%
9.28$896.42 million108,682159,171
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$18.92
+2.5%
N/A$860.29 million818,1511.14 millionAnalyst Revision
Rapport Therapeutics stock logo
RAPP
Rapport Therapeutics
$22.19
-0.4%
N/A$811.62 million125,319157,286
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$15.87
-2.1%
N/A$803.07 million256,485194,936
Wabash National Co. stock logo
WNC
Wabash National
$18.44
-0.6%
N/A$799.13 million406,387586,532Positive News
Avid Bioservices, Inc. stock logo
CDMO
Avid Bioservices
$12.22
+0.2%
N/A$779.51 million1.16 million1.32 millionPositive News
Prothena Co. plc stock logo
PRTA
Prothena
$14.40
+2.5%
N/A$774.86 million629,652583,077Analyst Downgrade
Analyst Revision
BlackRock TCP Capital Corp. stock logo
TCPC
BlackRock TCP Capital
$8.96
-0.7%
N/A$772.03 million315,501505,677Analyst Upgrade
Replimune Group, Inc. stock logo
REPL
Replimune Group
$11.23
+2.6%
N/A$768.36 million548,2791.03 million
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$74.42
+0.2%
47.95$757.60 million82,32772,682News Coverage
Positive News
Redwire Co. stock logo
RDW
Redwire
$11.02
-5.3%
N/A$733.28 million633,732357,690
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
$15.82
-1.8%
N/A$728.16 million212,265258,475
Entrada Therapeutics, Inc. stock logo
TRDA
Entrada Therapeutics
$17.93
+0.9%
11.28$670.94 million68,794107,214
Adaptive Biotechnologies Co. stock logo
ADPT
Adaptive Biotechnologies
$4.42
-1.3%
N/A$652.30 million1.82 million1.41 millionShort Interest ↓
Analyst Revision
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$20.31
+1.7%
N/A$618.03 million345,686352,044
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$20.77
-6.7%
N/A$614.79 million194,955205,596Short Interest ↑
TRML
Tourmaline Bio
$24.00
+2.1%
N/A$602.61 million154,298299,405
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.61
+6.6%
N/A$599.34 million3.16 million2.47 million
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
Immunome, Inc. stock logo
IMNM
Immunome
$9.33
-0.6%
N/A$582.35 million558,663772,027Analyst Revision
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$9.77
+2.4%
N/A$580.63 million204,686308,434Short Interest ↓
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$2.53
+7.2%
N/A$564.87 million2.06 million2.15 million
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$8.86
-0.6%
N/A$560.79 million31,06592,650
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$27.58
-0.1%
56.29$554.25 million170,044135,131
PureTech Health plc stock logo
PRTC
PureTech Health
$21.70
+2.1%
N/A$519.38 million2,0484,115Positive News
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$8.36
+0.6%
N/A$513.61 million736,090760,506
Grail, Inc. stock logo
GRAL
Grail
$15.09
+2.0%
N/A$507.04 million481,1661.09 millionInsider Trade
Short Interest ↑
News Coverage
ProKidney Corp. stock logo
PROK
ProKidney
$1.65
-8.3%
N/A$477.96 million329,693707,620News Coverage
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$9.63
+0.7%
N/A$477.07 million804,939623,574Analyst Forecast

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.


(Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.



More Stock Ideas from MarketBeat